Pre-Open Stock Movers 11/21: (HW) (LOCK) (MSTX) Higher; (TSN) (ACOR) (MTSI) Lower (more...)
- Oil steady around $50 on doubts over OPEC output cuts
- lululemon athletica (LULU) Tops Q3 EPS by 4c; Adj.-Comps Outpaced Views
- Costco Wholesale (COST) Tops Q1 EPS by 5c; Comps Up 1%, 2% Ex-Gas
- Universal Health (UHS) Disputes and Denies Conclusions in BuzzFeed Article
- Perrigo (PRGO) to Restructure BCH Omega Pharma Belgium Business; Will Terminate EuroGenerics Agreement
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Today's Pre-Open Stock Movers
Headwaters, Inc. (NYSE: HW) 18% HIGHER; announced that it has entered into a binding merger agreement with Boral Limited (BORAL: BLD:ASX) pursuant to which Boral will acquire Headwaters Incorporated for US$24.25 per share in cash, representing an aggregate enterprise value of approximately US$2.6 billion (Acquisition).
Tyson Foods (NYSE: TSN) 16% LOWER; reported Q4 EPS of $0.96, $0.21 worse than the analyst estimate of $1.17. Revenue for the quarter came in at $9.16 billion versus the consensus estimate of $9.38 billion. GUIDANCE: Tyson Foods sees FY2017 EPS of $4.70-$4.85, versus the consensus of $4.98.
LifeLock, Inc. (NYSE: LOCK) 14.6% HIGHER; Symantec Corp. (NASDAQ: SYMC) and LifeLock, Inc. (NYSE: LOCK) today announced that they have entered into a definitive agreement for Symantec to acquire LifeLock for $24 per share or $2.3 billion in enterprise value. The deal, which was approved by the boards of directors of both companies, is expected to close in the first calendar quarter of 2017, subject to customary closing conditions including LifeLock stockholder approval.
Mast Therapeutics, Inc. (NYSE: MSTX) 12.7% HIGHER; provided an update regarding its recently announced campaign to evaluate strategic opportunities. The Company has received several written indications of interest from privately-held companies, including companies with synergistic clinical-stage drug candidates, and is actively evaluating these opportunities.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) 8.5% LOWER; announced that the MILESTONE clinical study did not show sufficient efficacy to support further development of dalfampridine to improve post-stroke walking difficulties (PSWD).
Applied Micro Circuits Corporation (Nasdaq: AMCC) 7.5% HIGHER; MACOM Technology Solutions Holdings, Inc. (Nasdaq: MTSI) announced it has entered into a definitive agreement to acquire Applied Micro Circuits Corporation (Nasdaq: AMCC) for approximately $8.36 per share, consisting of $3.25 in cash and 0.1089 MACOM shares per share of AppliedMicro. This price for each share of AppliedMicro represented a 15.4% premium over the companys closing price of $7.25 on Friday, November 18th. MACOM intends to divest the well-positioned but non-strategic Compute business within the first 100 days of closing.
MACOM Technology Solutions Holdings, Inc. (Nasdaq: MTSI) 7.5% LOWER; announced it has entered into a definitive agreement to acquire Applied Micro Circuits Corporation (Nasdaq: AMCC) for approximately $8.36 per share, consisting of $3.25 in cash and 0.1089 MACOM shares per share of AppliedMicro. This price for each share of AppliedMicro represented a 15.4% premium over the companys closing price of $7.25 on Friday, November 18th. MACOM intends to divest the well-positioned but non-strategic Compute business within the first 100 days of closing.
International Game Tech (NYSE: IGT) 4.4% HIGHER; reported Q3 EPS of $0.45, $0.01 better than the analyst estimate of $0.44. Revenue for the quarter came in at $1.27 billion versus the consensus estimate of $1.25 billion. Outlook: The Company continues to expect adjusted EBITDA of $1,740-$1,790 million for the full year 2016 period. Capital expenditures excluding upfront Lotto concession payments are now expected to be no more than $550 million. This compares to previous capital expenditure guidance of $550-$580 million. Net debt is still expected to be $7,700-$7,900 million at the end of 2016.
YY, Inc. (NASDAQ: YY) 3.7% HIGHER; reported Q3 EPS of $1.12, $0.34 better than the analyst estimate of $0.78. Revenue for the quarter came in at $313.4 million versus the consensus estimate of $306.6 million.
Freeport-McMoRan (NYSE: FCX) 3.6% HIGHER; PT raised at Cowen
Cempra, Inc. (NASDAQ: CEMP) 3.5% LOWER; Cowen downgraded from Outperform to Market Perform.
ZTO Express (NYSE: ZTO) 3% HIGHER; Goldman Sachs initiated with a Buy rating and a price target of $19.00.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott (ABT) Files Complaint to Terminate Alere (ALR) Acquisition
- Pre-Open Stock Movers 12/05: (FRP) (GMED) (CHK) Higher; (CERC) (HDSN) (MRVL) Lower (more...)
- Abbott (NYSE: ABT) weekly volatility elevated, into seeking to terminate acquisition of Alere
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesGoldman Sachs, Cowen & Co, Pre-Open Losers, Pre-Open Winners, Definitive Agreement, Pre Market Movers
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!